ARCHIVES

Tafinlar Subgroup Data Shows Median OS of 20 Months

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

NCI Awards Regional CIS Contracts

August 6, 1993

CT Screening for Lung Cancer Unproven; Limit Use to Trials, Chest Physicians Urge.

September 14, 2007

St. Vincent Of NYC Joins Funded CCOPS Spurr To Be Professor Emeritus; UCOG, Still Unfunded, Still Active

May 1, 1987

Revlimid Plus Steroid Effective In Clinical Trial

November 30, 2007

An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists.

May 13, 2005

Sharp To Direct New Institute For Brain Research At MIT.

March 3, 2000